Insight

Drug resistance threatens core of healthcare

Emmanuelle Ingabire, from Kabgayi, was still in agony, suffering excruciating pain, her temperature at a burning level. She was vomiting and has general body weakness. All these were three days after she had completed her third course of treatment for a bout of malaria.  “It must be witchcraft,” said Ingabire’s neighbours as they looked at the emaciated young woman who was wasting away rather too fast. The strong smell of drugs wafting from her room would have made many a pharmacy downtown envious, yet Ingabire felt worse than ever. You can hardly blame her for despairing. Luckily for her, a younger brother in Kigali funded a visit to one of the private hospitals in the city where she was diagnosed with a drug-resistant strain of malaria.  The previous courses of medication had proved ineffective because the particular strain of malaria she was suffering from was resistant to the drugs she had been given. A different course of medication was prescribed and Ingabire was back on her feet in a few days.
The New Times
Solomon Asaba